Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori InfectionRecruiting
NCT07275827Phase 3Updated Sep 9, 2026
Sponsor: Tanta University
HELICOBACTER PYLORI INFECTIONS
Egypt
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)Recruiting
NCT07780669Phase 3Updated Sep 9, 2026
Sponsor: GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive
United States
A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With TezepelumabRecruiting
NCT07520162Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Chronic Rhinosinusitis With Nasal Polyps
China
Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip OsteoarthritisRecruiting
NCT04990128Phase 3Updated Sep 9, 2026
Sponsor: The Cleveland Clinic
Hip Osteoarthritis
United States
Continuation Study of Zasocitinib in Adults With Psoriatic ArthritisRecruiting
NCT07286058Phase 3Updated Sep 9, 2026
Sponsor: Takeda
Psoriatic Arthritis
United States, Australia, China, Croatia, Czechia +11 more
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2Recruiting
NCT04628026Phase 3Updated Sep 9, 2026
Sponsor: University of Ulm
Acute Myeloid Leukemia
Austria, Belgium, Estonia, Finland, Germany +3 more
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)Recruiting
NCT07701993Phase 3Updated Sep 9, 2026
Sponsor: GlaxoSmithKline
Metabolic Dysfunction-associated Steatohepatitis
United States, Japan
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesRecruiting
NCT07648264Phase 3Updated Sep 9, 2026
Sponsor: CSL Behring
Secondary Immune Deficiency
United States, Belgium, Canada, Czechia, Denmark +6 more
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)Recruiting
NCT07549412Phase 3Updated Sep 9, 2026
Sponsor: EMD Serono Research & Development Institute, Inc.
Metastatic Colorectal Cancer
United States, Argentina, Australia, Austria, Belgium +11 more
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)Recruiting
NCT07218029Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Pulmonary Arterial Hypertension
United States, Argentina, Australia, Belgium, Brazil +22 more
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet ChemotherapyRecruiting
NCT07225270Phase 3Updated Sep 9, 2026
Sponsor: Genmab
Ovarian Cancer · Platinum-sensitive Ovarian Cancer · PSOC
United States, Belgium, Japan
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.Recruiting
NCT06626022Phase 3Updated Sep 9, 2026
Sponsor: University of Alberta
Prostate Cancer Screening
United States, Canada, France, Norway, Spain
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)Recruiting
NCT06667700Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Coronavirus Disease (COVID-19)
United States, Argentina, Brazil, Bulgaria, Colombia +19 more
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsRecruiting
NCT07435428Phase 3Updated Sep 9, 2026
Sponsor: Ipsen
Moderate to Severe Glabellar Lines
United States, France, Germany, Japan
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)Recruiting
NCT07554339Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Brazil, China +11 more
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney DiseaseRecruiting
NCT05312879Phase 2, Phase 3Updated Sep 9, 2026
Sponsor: Vertex Pharmaceuticals Incorporated
Proteinuric Kidney Disease
United States, Belgium, Brazil, Canada, Colombia +8 more
52-week Open Label Safety-Tolerability StudyRecruiting
NCT07369154Phase 3Updated Sep 9, 2026
Sponsor: LB Pharmaceuticals Inc.
Schizophrenia
United States
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaRecruiting
NCT07571109Phase 3Updated Sep 9, 2026
Sponsor: Novo Nordisk A/S
Obesity · Overweight · Obstructive Sleep Apnoea
United States, Australia, China, Germany, India +5 more
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesRecruiting
NCT06671483Phase 3Updated Sep 9, 2026
Sponsor: Takeda
Psoriatic Arthritis
United States, Belgium, Bulgaria, Chile, Croatia +15 more
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus ErythematosusRecruiting
NCT07430306Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
United States, Canada, France, Germany, Italy +4 more
Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.Recruiting
NCT06897644Phase 3Updated Sep 9, 2026
Sponsor: Gruppo Oncologico del Nord-Ovest
Pancreatic Adenocarcinoma Advanced or Metastatic
Italy
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaRecruiting
NCT05757102Phase 3Updated Sep 9, 2026
Sponsor: GlaxoSmithKline
Asthma
United States, Argentina, Australia, Chile, Israel +4 more
A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand DiseaseRecruiting
NCT06998524Phase 3Updated Sep 9, 2026
Sponsor: Hoffmann-La Roche
Von Willebrand Disease, Type 3
United States, Belgium, Canada, Colombia, France +9 more
A Prospective, Single-center, Non-randomized, Interventional Study on the Effectiveness and Safety of Combined Immunotargeted Therapy in Patients With Metastatic Non-small Cell Cancer With a RET Gene TranslocationRecruiting
NCT07809256Phase 3Updated Sep 9, 2026
Sponsor: EuroCityClinic LLC
NSCLC (Non-small Cell Lung Cancer)R
Russia
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)Recruiting
NCT06430801Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Crohn's Disease
United States, Australia, Austria, Belgium, Brazil +42 more

Previous page Next page